The COVID-19 pandemic validated how essential pharmacists are in providing patients care, services and vaccines. In this podcast — held at Cardinal Health’s annual Retail Business Conference (RBC) in Boston — Congressman Buddy Carter and Doug Hoey, CEO of the National Community Pharmacists Association (NCPA), address how they’re advocating to elevate the inherent value pharmacies bring to the healthcare industry. They also address the importance of accessibility, affordability and quality in healthcare. Listen in as Congressman Carter and Hoey talk about the Equitable Community Access to Pharmacist Services Act (H.R. 1770, S. 2477), a provider status bill that—if passed—would enable Medicare patients to receive timely and consistent treatment from pharmacists for pandemic-related health services, and would provide a federal reimbursement to pharmacies under Medicare Part B for treatment and services rendered. They also address the current and future state of pharmacy not only through a legislative lens but also how this industry can be positively impacted by advocacy and grassroots efforts.  About Congressman Buddy Carter: U.S. Representative Carter is serving his fifth term in the U.S. House of Representatives and is a member of the House Energy and Commerce Committee and the House Budget Committee. He’s the former mayor of Pooler, GA, a former Georgia General Assembly member, a pharmacist and past owner of Carter’s Pharmacy, Inc. With more than 30 years of experience in pharmacy, he is dedicated to working on behalf of pharmacies to expand their role and interaction with patients.  About Doug Hoey: Hoey is the CEO of the National Community Pharmacists Association (NCPA), is a licensed pharmacist in Oklahoma, Virginia and Texas, and has practiced in various pharmacy settings. He is viewed as a pillar of advocacy as he’s spent the last 20+ years working in and representing community pharmacies. 

In this episode: What is Purpose and how do we define it? Why does it matter to have Purpose in our careers? Ikigai and how we can use it to define our career A career without purpose is devoid of meaning… it is lifeless! And that’s why we quit sometimes…that’s why I quit at some point! Purpose is that connection you have with life. It is your reason for being. Your reason for waking up every day—when that is lost, we feel lost! So, if you’re a pharmacist who is struggling with purpose in your career and life, give this a listen! Visit www.katrinaazer.com to find out how I can help you:  Figure out what your purpose is and how you can weave that into your career  Get coached into figuring out and building your dream career  Find out how to build a side hustle that earns you income  Bring Pharmacogenomics & Telepharmacy to your practice Follow me on social media:  LinkedIn: https://www.linkedin.com/in/katrina-azer/  Facebook: https://www.facebook.com/pharmxcel Twitter: https://twitter.com/Kat_pharmacist The PharmXcel Podcast is a show for pharmacists who want to connect with why they did pharmacy and how to build a fulfilling career by addressing the opportunities and challenges that make us pharmacists—Pharmacists who signed up for pharmacy to help transform patient lives! Thanks for listening in—it means the world to me! Here is how you can support my mission: Give it a 5-star rating wherever you’re listening to it Share this with other Pharmacists who would enjoy it Subscribe to get notified of new episodes And please reach out if you have any questions or comments! Your feedback will help me bring you valuable content.

WELCOME BACK to PART TWO of three of the Converge LIVE Recap Show! With guests: Dr. Dana Gordon, PharmD Gail Lebovic, MA, MD, FACS - CEO at Silicon Valley Innovations, Inventor of NasoClenz   Bill Holmes - CEO of RxSafe   Jessica Socorro - Senior National Account Manager of Real Value Rx   Larry Stephenson - Vice President Of Strategic Sales at Transaction Data Systems now called Outcomes

Explore the realm of pharmacogenomic testing as patients open up about their experiences, sharing stories of both success and tragedy. These courageous guests provide insights into the power of personalized medicine and the crucial lessons learned along the way. A journey from medication struggles to success through pharmacogenomics. A heartbreaking tale of genetic-based medication complications. Navigating emotions while uncovering genetic insights. Triumphs of Personalization: Guests share uplifting accounts of renewed health and life improvements due to pharmacogenomic testing. Learning from Tragedy: Stories underscore the consequences of neglecting genetic factors, advocating for greater awareness. Emotional Resilience: Discussing the psychological challenges in the context of chronic conditions and medication adjustments. Empowering Patients and Providers: Guests stress education and dialogue between patients and medical professionals for informed decisions. Join us as we unravel narratives of strength, hope, and knowledge in pharmacogenomic testing. This episode provides a valuable perspective on the fusion of genetics and healthcare, whether you're a patient, healthcare provider, or simply intrigued by personalized medicine's evolution. Special interviews with Christina Delsoldato, Karen Merrit, Christine Von Raesfeld, and Joanne McIntyre. Behnaz Disclaimer: These are my personal views and opinions, and I am not speaking on behalf of Castle Biosciences, Inc.

The #SexPharmD Dr. Nadia Archambault, PharmD talks with Jennifer Stone PT, DPT, about how physical therapy can have a direct impact on #sexualhealth. By working together, physical therapists, pharmacists, and sexual therapists can provide holistic care that addresses the physical, pharmacological, and psychological aspects of a patient's health and well-being. Shares these podcasts with your colleagues and patients. #TogetheRx we're transforming #PharmacyCare. CPESN Networks https://evidenceinmotion.com/people/jennifer-stone/

We're excited about TWIRx this week with 2 Pharmacy Podcast Network hosts joining the show! Our first guest is our newest host, Anisha Patel, founder of Pharmacist Diaries, a podcast that reveals the secret lives of pharmacists, from where their journeys began, where they are now and everything in between.  Our next guest was voted as one of the most influential Pharmacists for 2022, Dr. Anne Arvizu PharmD is the founder of the 'Core Life Method' - transformational coaching techniques! 

Join us in our final part of the 2023 Profit Summit Live!   Speakers: Mike Johnston - President of NPTA Thomas Napolitano - Senior VP of Real Value Rx JP Collier - Real Value Rx Hussam Hamoush, PharmD - Sports Pharmacy Podcast Karen Deckard - Director of Sales and Marketing at RMS Solutions Patti Mara - CEO & Founder of Pharmacy Success Jeff Hedges -  RJ Hedges rjhedges.com Ajay Mehra - UGO Heather Haro - DiversifyRx

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, sits down with Dr. Paige Kilian, Chief Medical Officer (CMO) for Inovalon, to discuss the outsized role administrative burden is playing in driving primary care physicians and pharmacists out of the patient communities that need them, what we need to do to fix it, and what is possible once we do.

On this episode of the Pain Pod, we discuss the intersection of pain management, our geriatric patient population, and the 2023 AGS Beers Criteria Update. Let’s face it, if you’re not geriatric (65yo or even more experienced), you hope to be one day! So, this episode is right up everyone’s alley. A discussion of Centenarians (not the Roman soldier Centurions, rather those living to be at least 100yo)! Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us 2023 AGS Beers Criteria (Article •https://agsjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.18372 JAGS • https://agsjournals.onlinelibrary.wiley.com/journal/15325415 AGS • https://www.americangeriatrics.org/  

Discussing psychedelic therapy in Autism Spectrum Disorder, and considerations for patients and clinicians working with patients with autism in psychedelic therapy sessions. Aaron Orsini is an autistic psychedelic educator, author and researcher. He has published four books about his area of focus — Autism On Acid (2019), Autistic Psychedelic (2021), Introduction to Psychedelic Autism (2022), and Psychedelic Autism (2023) — and presently serves as a psychedelic autism research co-author collaborator to University College London and an advisor to an ADAPT drug education study funded by Organization for Autism Research. Aaron is also a lecturer on psilocybin facilitation for Alma Institute and SoundMind Institute in Oregon, Naropa University in Colorado, and the lead instructor for his first-of-kind facilitation-focused intensive offered via AutisticPsychedelic.com. He presently lives in Denver where he is focused on creating decentralized and affordable community care models that can offer psilocybin & other natural medicines through grow, gift, and get-together approaches. Aaron is also available for one-on-one consultations, advising positions, and other educational appearances at conferences and events, and can be reached anytime at [email protected] AutisticPsychedelic.com is an online hub & educational resource for autistic individuals as well as the friends, family, and professionals who seek to support autistic individuals in various psychedelic contexts. The Autistic Psychedelic.com Community is an online resource and meeting point for autistic individuals as well as the friends, family, and professionals who seek to support autistic individuals in various psychedelic contexts. Founded in 2020, this global community offers peer support meetings, resource libraries, monitored chat forums, podcasts, video presentations, and immersive educational opportunities, including the first-of-its-kind “Introduction to Psychedelic Autism” textbook & learning intensive designed with therapists and facilitators in mind. For more information about upcoming meetings, events, online courses, conferences and more, please visit AutisticPsychedelic.com. Aaron is also available for individual counseling and questions at his website: aaronorsini.com

Step into the world of innovation, retail, and healthcare as we bring you the electrifying Part One of Converge LIVE: The NACDS Total Store Expo. Join us for an immersive experience as we explore the intersection of technology, pharmacy, and retail, featuring a lineup of influential leaders who are reshaping the industry. In this episode, we're honored to be joined by a panel of visionaries: Lori Schafer, the dynamic CEO of Digital Wave Technology, Inc., who is redefining the tech landscape with transformative solutions. Pano Anthos, the brilliant Founder & Managing Director of XRC Ventures, whose expertise in retail innovation is driving the evolution of the shopping experience. Dr. David Pope, PharmD, from Omnisys, shares his insights into the evolving role of pharmacists in delivering comprehensive healthcare solutions. Dr. Michael Hogue, PharmD, representing the American Pharmacists Association, discusses the integration of technology in modern pharmacy practices and its impact on patient care. Breck Rice, the forward-thinking Chief Revenue Officer & Co-Founder of ServRx, unveils the seamless fusion of technology and pharmaceutical services.

Today I talk with a fellow pharmacist who became a patient going through our healthcare system, desperate for answers and having to advocate for herself from the other side of the treatment counter. We discuss what it takes to stay healthy in today’s post-COVID world when so much remains shrouded in mystery, and yet going back to the basics of self-care can still make a difference. Long-COVID symptoms are very real and affect a significant part of the population. As healthcare providers it behooves us to gain a general understanding of the disease so we can be there for our patients and provide them with symptom mitigation strategies. Salam Kabbani is an infectious diseases pharmacy specialist at Olathe Medical Center. She graduated with her doctor of pharmacy degree from California Health Sciences University in 2019 and then went on to complete a PGY1 pharmacy residency at Cleveland Clinic South Pointe hospital. Despite being fully vaccinated at the time, she had a breakthrough COVID infection with the delta variant in August of 2021 which was then followed by a long-COVID journey.  Becoming disabled changed her life in so many ways both good and bad, and she decided to write a memoir detailing her long-COVID journey to raise awareness about the condition, and most importantly to let other long-haulers know that they are not alone and they matter. She is now proudly a patient advocate and believes in spreading empathy through honest and open communication. Her book “COVID Long-Hauler: My Life Since COVID” is available in print, ePub, and audiobook and can be found on Amazon. Connect with Salam via: www.authorsalam.com   LinkedIn: linkedin.com/in/salamkabbani Instagram: @longhaulerchronicles / @theunabridgedlifeofsalamacita

ComputerTalk's Maggie Lockwood previews SoftWriters' 13th annual FrameworkLTC User Conference. On this roundtable discussion, the team from SoftWriters discuss the theme of "Build, Partner, Serve." In addition, hear from a FrameworkLTC customer talk about the benefits of attending this event.   • Aaron Nalick, Director, Partnerships • Mark Fulton, Director, Product Regulatory Compliance • Daniel Green, Director of Long-Term Care, Alps Pharmacy • Dustin Harbison, Director of Account Management. Hosted by Maggie Lockwood, Director of Production at ComputerTalk. 

Dr. Michael Steinman: linkedin.com/in/mike-steinman-50ba117 Dr. Scott Stewart: linkedin.com/in/scott-stewart-34973870 Dr. Tamara Ruggles: linkedin.com/in/tamara-ruggles-491882251 US Deprescribing Research Network: https://deprescribingresearch.org/ 2023 Updated AGS Beers Criteria: https://agsjournals.onlinelibrary.wiley.com/doi/full/10.1111/jgs.18372  

CURE ID is an internet-based repository that allows the global community to report novel uses of existing drugs for difficult-to-treat diseases through a website, a smartphone, or other mobile device. In this episode, FDA's Division of Drug Information interviews Ms. Heather Stone, FDA’s health science policy analyst in the FDA’s Office of Medical Policy, and Dr. Marco Schito, Executive Director of the Critical Path Institute’s CURE Drug Repurposing Collaboratory, or CDRC to discuss the benefits and future of CURE ID.

In this lively and informative episode, Dr. H welcomes David Gerson, the creator of "Refs need love too" on TikTok, to the Sports Pharmacy podcast. David shares his journey from being a former division one rugby player to becoming a referee, inspired by his son's interest in officiating soccer at a young age. As a nationally certified rugby referee, David found a passion for reffing and decided to combine it with his marketing expertise to create engaging content on TikTok. The conversation delves into the world of refereeing, discussing the physical and mental demands referees face during games, as well as the challenges of making split-second decisions in fast-paced matches. They highlight the importance of communication between referees and players and how it can prevent potential conflicts on the field. David's TikTok videos not only provide humor and entertainment but also serve as a platform to educate viewers about the laws of the game and the decision-making process of referees. He emphasizes the need to humanize referees and show that they are dedicated individuals who love the sport just as much as players and fans. Throughout the episode, Dr. H and David exchange anecdotes and insights from their own experiences as referees, reminiscing about the joys and challenges they encountered in their officiating careers. They touch upon the evolution of refereeing and how technology like VAR (Video Assistant Referee) has impacted the game. Furthermore, David reveals his passion for maintaining fitness and how he hopes to continue refereeing for many more years, emphasizing that age should not deter anyone from pursuing a referee career. Dr. H also takes the opportunity to discuss health and wellness tips for athletes, specifically recommending magnesium glycinate as a beneficial supplement for relaxing muscles and combating fatigue. Overall, this episode is a captivating blend of personal experiences, sportsmanship, and tips for aspiring referees, athletes, and sports enthusiasts. It sheds light on the vital role referees play in the game and the importance of treating them with respect and understanding. Listeners will gain a newfound appreciation for the dedication and hard work that goes into being a referee and the impact they have on the beautiful game of soccer.

The triangle of care that should exist between patients, pharmacists & physicians has been under deadly fire from healthcare private corporatization for decades. As independent pharmacy healthcare providers, is there a way to stem the bleeding?   This month’s special guest Jeffrey Lewis, President and CEO of the Legacy Health Endowment and the EMC Health Foundation, might just have one. Both Legacy Health and EMC Health are nonprofits that are able to raise and provide funding for patients, independent pharmacies, and even students in their local area - using fundraising tactics based squarely in advocacy. It just goes to show, there’s always a solution… it just may not be the most obvious one!

Our host, Todd Eury, sits down with a lineup of trailblazers who are revolutionizing the pharmacy landscape and making a lasting impact. In the first interview, we have the privilege of speaking with Debbie Marcello, the visionary Founder and CEO of Happier at Home. Discover how her Long Term Care business is transforming the lives of seniors by providing them with the care they need while allowing them to age gracefully in the comfort of their own homes. Next up is Amantha Bagdon, the brilliant mind behind RxPost. Dive into the world of cutting-edge pharmacy technology with Michael Willner, PharmD, from Liberty Software. Gain insights into how Liberty Software is streamlining pharmacy operations and facilitating seamless patient care through innovative digital solutions. Kevin Walker, PharmD, Co-Founder of RPhAlly, takes the spotlight in our next interview. Discover how RPhAlly is fostering a supportive community for pharmacists, uniting them through shared experiences and empowering them to thrive in their careers. Kyle McCormick, PharmD, of Blueberry Pharmacy, joins us to discuss the intersection of personalized patient care and modern pharmacy practices. Uncover how Blueberry Pharmacy is enhancing the patient-pharmacist relationship and redefining the role of community pharmacies. We have a captivating conversation with Matt Gilbert, the dynamic VP of Sales at RxSafe. Explore the innovative solutions RxSafe offers to pharmacies, optimizing medication management and revolutionizing the way prescriptions are dispensed. Whether you're a pharmacy professional, a healthcare enthusiast, or simply intrigued by entrepreneurial success stories, this episode of "Becoming a Pharmacy Badass" is a must-listen. Join us as we delve into the minds of these remarkable individuals who are reshaping the future of pharmacy and leaving their mark as true industry badasses. Tune in and get ready to be inspired on a whole new level!

Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, we deliver accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Our treatments are defined by our commitment to applying technical and scientific rigor and patient-centric design to the development process.  This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. We are continuously expanding and refining our shared platform technologies with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. Digital therapeutics under development on our platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, cardiology and immunology.  Consistently named a best place to work, we foster an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in our mission to provide patients everywhere access to safe and effective prescription digital therapeutics.

https://www.veozah.com/

Cannabis Usage in Medicine must be Rooted in Education (GUEST 1) Jeff Lombardo PharmD, BCOP  University at Buffalo Director Pharmacy Business Development - Catholic Health System The University at Buffalo Center for Integrated Global Biomedical Sciences (CIGBS) will partner with Charlotte’s Web Labs (CW Labs) on a research initiative to advance understanding of the therapeutic uses of cannabinoids. https://www.buffalo.edu/news/releases/2020/11/037.html Ref Research: Indigenous Medicine, Natural Products and Nanomedicine https://www.buffalo.edu/integratedglobalbiomedicalsciences/projects/Indigenous-medicine.html Dr. Stephen Cutler is the Dean and Professor USC College of Pharmacy, as a contributing source of data, research, and discussion in specific cases and cannabis usage. Partnerships in Cannabis helping to fund continuing education (GUESTS 2 & 3)Jameson Rodgers & Amir Nezhad  CBDfx   https://cbdfx.com/about/  [email protected] CBDfx is a CBD (cannabidiol) company based in Southern California. CBDfx specializes in quality cannabinoid wellness products that promote better health for the mind and body. Our popular organic hemp products include CBD gummies, CBD oil, CBD cream, and CBD for pets.  

Welcome to another exciting episode of Becoming a Pharmacy Badass! In this special installment, we're bringing you the highlights from the electrifying "Profit Summit Live 2023." Get ready to be inspired and empowered as we dive into conversations with some of the most trailblazing minds in the pharmacy world. Join your host Todd Eury as he sits down with industry mavericks who are redefining the pharmacy landscape. First up, we have Adam Robinson, PharmD, sharing his invaluable insights on navigating the complex world of pharmaceuticals. Gain a fresh perspective on industry trends, patient care, and the challenges and opportunities that lie ahead. Marie Wilda and Kristin Speer, both esteemed PharmDs, bring their documentary Would You Like Shots with That to the stage. Visit shotswiththat.com for more information Ezriel Green, PharmD, the visionary founder of EzriRx, takes us on a journey into the intersection of technology and pharmacy. Discover how cutting-edge solutions are streamlining medication management, improving adherence, and revolutionizing the way we think about pharmaceutical care. Visit EzriRx.com And that's not all! Join us for an insightful conversation with Dan Benamoz, a true luminary in the field. With his vast experience and expertise, Dan offers pearls of wisdom on entrepreneurship in pharmacy, building successful ventures, and staying ahead in a dynamic industry. Whether you're a seasoned pharmacist, a pharmacy student, or simply curious about the future of healthcare, this episode is your golden ticket to the pulse of pharmacy innovation. Get ready to level up your pharmacy game and become a true badass in the field. Tune in to Becoming a Pharmacy Badass for a front-row seat to the thought-provoking discussions and groundbreaking ideas presented at the Profit Summit Live 2023. Your journey to becoming a pharmacy badass starts here!

Thomas McDowell is a 4th generation Community Pharmacist and owner of McDowell’s Pharmacy in Scotland Neck, NC and Rocky Mount Medical Park Pharmacy in Rocky Mount, NC.  McDowell’s Pharmacy has been owned and operated by the McDowell family for over 100 years. Thomas purchased Rocky Mount Medical Park Pharmacy in 2021 to bring his passion for empathetic patient care and personalized service to the Nash County area.   Over the years, Thomas has seen an increased need for in-home care, especially for his pharmacy patients, which is why he has branched into the home care service industry.  Their patients trust them for the highest level of customer care and Thomas will continue to provide this superior service in the home care setting. So many families today do not know where to turn when it comes to senior care.  There are many incredible facilities in the community but often the loved one desires to stay in their home.  Loved ones may need help with medication management, doctor’s appointments,  taking care of their homes, or daily chores.  Thomas has seen this need and is committed to helping families and their loved ones maintain their independence for as long as possible.  Happier at Home – Eastern North Carolina will allow them to provide in-home care for seniors and the disabled, as well as comprehensive geriatric care management. Thomas currently volunteers with numerous groups including CPESN-NC, Area L AHEC, the UNC Eshelman School of Pharmacy Eastern Advisory Committee, and Scotland Neck Rising, a non-profit dedicated to economic revitalization and historic preservation.  He is happily married to his wife, Blaine, and has two beautiful children, Press and Mary Hayes. 

In this episode of FrameworkFocus, we delve into the world of regulatory compliance in long-term care with experts Donna Adendorff & Jamie Butler from The Compliance Store. This valuable resource supports skilled nursing facilities in meeting regulatory requirements efficiently. We explore the collaborative efforts required to achieve and maintain compliance, discussing its crucial impact on LTC quality. We also address post-COVID-19 challenges, staffing issues, payment concerns like PDPM, and the complexities of operations in LTC. 

Dr. Regina Moore, PharmD The Psychedelic Pharmacists Association is PsychedelicPharmacist.org. The PPA is unique as an organization focused on psychedelics and healthcare professionals as we do not require licensure for entrance and are open to the public to join.   Here is a link to the chart with drug harms https://www.businessinsider.com/chart-drugs-that-cause-the-most-harm-2013-9 . Journal is behind   New Zealand replicated this and published this year https://www.dailymail.co.uk/news/article-12240599/Alcohol-harmful-meth-cigarettes-worse-heroin-says-NZ-research-vapes-cannabis-rated.html   Here’s a more recent publication by Roland Griffiths et al on psychedelics and palliative care: https://pubmed.ncbi.nlm.nih.gov/34958455/   From the PPA here is our “top papers of the psychedelic renaissance” write up for those focused on studies: https://psychedelicpharmacist.org/top-psychedelic-research-papers/   You can find me at ReginaMoore.me and [email protected]   Lisa Solomon's Contact: [email protected]

We are continuing the conversation around academic detailing and opioid safety with Illinois ADVANCE. We will touch base on our FDA REMS Opioid Education grant and how this unique opportunity can be implemented nationwide. We will delve into the topic of Opioid Use Disorder, updates with the X-waiver, and strategies to combat the opioid epidemic via peer-to-peer discussions. We will also chat about the benefits of using academic detailing as a resource for evidence-based, non-biased, up-to-date practice recommendations. Our goal is to connect with other pharmacists to ensure we are working at the top of our license potential. We look forward to spreading the word on this new and exciting style of education.

The Drug Supply Chain Security Act has been a decade in the making. Pharmacists must be prepared to comply by November 2023. The National Association of Boards of Pharmacy (NABP) has been working with state boards of pharmacy to update inspection standards and procedures, said Josh Bolin, associate executive director for Federal Affairs and Strategy at NABP.  "After November 27, 2023, states will be unable to enact any tracing requirements that go beyond the obligations laid out in DSCSA but.. will check for DSCSA compliance", he noted, adding the "one of the open questions is enforcement discretion in the early period. We will continue to work with our partners as November grows closer." 

Children's Book Authors & Pharmacy Students Shay Roth & Jaccie Hisashima join "This Week in Pharmacy"   Jaccie Hisashima – University of Pittsburgh School of Pharmacy. Now completing a PGY1 Acute Care Residency at UC Davis Medical Center, Sacramento. Shay Roth, PharmD Candidate 2024 University of Pittsburgh School of Pharmacy, Co-Author and Illustrator

In this episode of the Sports Pharmacy Podcast, host Dr. H is joined by Dr. Alex Capano, a PhD in cannabinoid studies, to discuss the benefits and stigma surrounding CBD (cannabidiol). Dr. Alex shares her journey from neuroscience and chemistry studies to becoming a family nurse practitioner and eventually specializing in cannabis medicinally. The conversation delves into the importance of studying cannabis, destigmatizing its use, and providing patients with alternative therapeutic options to potentially harmful substances. Dr. H opens up about his personal connection to opioid alternatives, highlighting the need for better pain management solutions, especially in the world of sports. Dr. Alex emphasizes the responsible use of opiates when necessary but also highlights the potential of CBD and other cannabinoids in managing pain, particularly among athletes dealing with post-game pain or playing while injured. They discuss the experiences of professional athletes and the challenges they face in finding safe alternatives to manage pain and recover from injuries.

Exploring the latest research on psilocybin for TBI and chronic pain Adkins A and Ferguson MC. “Research update: MDMA and psilocybin for pain management.” Practical Pain Management. 18 June 2022. https://www.practicalpainmanagement.com/news/research-update-mdma-and-psilocybin-for-pain-management. Accessed 30 July 2023 Bornemann J, et al. “Self-medication for chronic pain using class psychedelics: A qualitative investigation to inform future research.” Frontiers in Psychiatry. 18 June 2022. https://www.practicalpainmanagement.com/news/research-update-mdma-and-psilocybin-for-pain-management Accessed 31 July 2023. Fanciullacci M, et al. “Brief report: phantom limb pain: sub-hallucinogenic treatment with lysergic acid diethylamide (LSD).” Headache. 1977 July; 17(3): 118-119. https://pubmed.ncbi.nlm.nih.gov/893080/ Accessed 30 July 2023 Flanagan T, Nichols C. “Psychedelics as anti-inflammatory agents.” Psychedelic Research. 13 Aug 2018. Accessed 28 July 2023. https://blossomanalysis.com/papers/psychedelics-as-anti-inflammatory-agents/ Hawryluk M. “Pain, hope, and science collide as athletes turn to magic mushrooms.” WUSF Public Media. 30 Apr 2023. https://wusfnews.wusf.usf.edu/health-news-florida/2023-04-30/pain-hope-and-science-collide-as-athletes-turn-to-magic-mushrooms Accessed 30 July 2023. Kooijman NI, et al. “Are psychedelics the answer to chronic pain: A review of current literature.” Pain Pract. 2023 Apr;23(4):447-458. Accessed 30 July 2023. doi: 10.1111/papr.13203. Epub 2023 Jan 11. PMID: 36597700. “Lobe Sciences announces launch of pre-clinical study in collaboration with the University of Miami Miller School of Medicine.” Newsfile. 30 Nov 2020. Accessed 27 July 2023. https://www.newsfilecorp.com/release/69106/Lobe-Sciences-Announces-Launch-of-Preclinical-Study-in-Collaboration-with-the-University-of-Miami-Miller-School-of-Medicine Made, Rachel. “Jim Harris was paralyzed. Then he ate magic mushrooms.” Outside. 9 Nov 2022. Accessed 27 July 2023. https://www.outsideonline.com/outdoor-adventure/exploration-survival/psychedelics-research-paralysis-treatment-jim-harris/ Mansoor Khan S, et al. “Psychedelics for brain injury: a mini review.” Frontiers in Neurology. 2021(12). 29 July 2021. Accessed 28 July 2023. https://www.frontiersin.org/articles/10.3389/fneur.2021.685085/full Price S. “Data shows combination psilocybin therapy effective for TBI and PTSD.” Psychedelic Health UK. 30 Sept 2021. Accessed 30 July 2023. https://psychedelichealth.co.uk/2021/09/30/data-shows-combination-psilocybin-therapy-effective-for-tbi-and-ptsd/ Rauchman B. “UFC fighter’s brain injury successfully treated with psychedelic therapy.” Pacific Neuroscience Institute. 6 July 2023. Accessed 28 July 2023. https://www.pacificneuroscienceinstitute.org/blog/trip/ufc-fighters-brain-injury-successfully-treated-with-psychedelic-therapy/ Ramachandran V, et al. “Relief from intractable phantom pain by combining psilocybin and mirror visual feedback (MVF).” Neurocase. 2018 Apr; 24(2): 105-110. Accessed 29 July 2023. https://pubmed.ncbi.nlm.nih.gov/29764303/ Rosenhall U, et al. “Treatment of military acoustic accidents with n-acetyl-l-cysteine (NAC). Int J Audiology. 2019 March; 58(3): 151-157. Accessed 30 July 2023. https://pubmed.ncbi.nlm.nih.gov/30653365/ Schindler et al. “Exploratory investigation of a patient informed low dose psilocybin pulse regimen in the suppression of cluster headaches: results from a randomized, double-blind, placebo-controlled trial.” Headache. 23 Nov 2022. https://headachejournal.onlinelibrary.wiley.com/doi/abs/10.1111/head.14420 Accessed 30 July 2023. “Traumatic Brain Injury and Concussion.” Centers for Disease Control. Last Reviewed: 7 July 2023. Last access 29 July 2023. https://www.cdc.gov/traumaticbraininjury/data/index.html

https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive

Hello everyone, I’m super excited to release this next episode that was recorded at the start of this year. We covered so many topics near and dear to my personal and professional mission and I’m so honored to introduce my next guest and what he is contributing to healthcare. Dr. Rohit Moghe is an ambulatory care & population health clinical pharmacist for accountable care organization (ACO) at Trinity Health Mid-Atlantic. He is originally from the Philadelphia area. Dr. Moghe is a residency-training pharmacist with a master's in public health and a certified diabetes care & education specialist with over 22 years of experience across various therapeutic areas and whole continuum of care. Dr. Moghe is active in leadership at both Association of Diabetes Care & Education Specialists as well as American College of Lifestyle Medicine as Co-Chair of the pharmacist group. His diverse professional and life experience has led him to understand that most chronic conditions don't need to be managed with medications. However, if we must use them, we should be delivering comprehensive medication management (CMM) and get paid for the work that we do. His specialty is deprescribing medications, BUT, if they are to be ramped down, we must ramp up people's lifestyle. He uses the six pillars of lifestyle medicine: nutrition, enjoyable physical activity, restful sleep, addressing stress, reducing risky behaviors (& substances), and positive social connections. The stuff we should all optimize, but always pay enough attention to it. He focuses a lot on coaching his patients and clients through change. He is also a 200-hr yoga teacher registered through the Yoga Alliance and practices many forms of meditation and deep breathing exercises. Having grown up in yoga since an early age, application of Ayurvedic principles in his lifestyle come naturally to him, including appropriate use of herbal and natural remedies.

Tips for understanding and managing your wholesaler's primary vendor agreement.  Scott Patterson, owner of 6 pharmacies joins Scott Wittnebel, Director of Pharmacy Services for IPC talk about strategies and tactics you can use to maximize your rebates and lower you cost of goods.

Ken Chahine, founder and CEO at Nectar Life Sciences on your radar. Ken has a fascinating story: a child of immigrant parents, neither of whom finished elementary school, he earned a PhD in Biochemistry (U of Michigan) and a JD in patent law.  After transforming the field of genetic testing for genealogy as General Manager of Ancestry DNA, he founded Nectar, a health tech company revolutionizing the allergy space with at-home allergy testing and treatment with sublingual drops. In grad school, Ken suffered from severe allergies that made lab work in goggles near-impossible. When he discovered the healthcare system’s solution for chronic allergy sufferers is constant medications (average = 3 meds per day) and/or painful, inconvenient shots, he knew there had to be a better way. Just a sample of what Ken can elaborate on: First-hand experience with allergies as a chronic condition and advocating for the consumer  Long-term benefits of at-home allergy testing + treatment Why sublingual (under the tongue) treatment is already standard in Europe as a safer alternative to subcutaneous (shots) How he transitioned into the allergy space after revolutionizing the genetic science behind Ancestry.com Predictions for holistic approaches in the healthcare space

Controlled substances, including opioids, benzodiazepines, and medical cannabis, are commonly prescribed for the treatment of chronic pain. Urine drug screens (UDS) are often used in clinical practice to test for the presence of prescribed drugs to monitor compliance. Understanding how to appropriately interpret the results of urine drug screening is critical to providing effective patient care and maintaining patient trust. Pharmacists in various practice settings can play important roles in urine drug screenings. The goal of this podcast is to provide pharmacists and other clinicians with insight and information for appropriately interpreting urine drug screening results. The conversation will focus on the types of drug screening panels, possible causes of false- positives and negatives, and how metabolism of drugs can impact urine drug screening results. Tips on how to effectively have conversations with patients that can be difficult will also be part of the discussion. This activity is supported by a grant from the Providers Clinical Support System (PCSS). Funding for this initiative was made possible (in part) by grant no. 6H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.    

Success in launching new therapies for rare diseases (RDs) implies the ability for the manufacturer to achieve a level of reimbursed price and a level of market access that are commercially viable on the market. Access to RD therapies is challenging because the legal and policy frameworks may be absent, funding may be insufficient and/or payers do not see the justification with the prices for these therapies. The industry has, however, a real opportunity to partner with healthcare stakeholders.  There needs to be continued support to provide the education towards payers, drive evidence-based pricing, and innovative contracting, and address the multiple hurdles of access for these unique therapies. But how do we price and how do we gain access on the promise of long-term value when we don’t have the long-term data on these new therapies?  That is why all stakeholders need to address early market access planning, including inclusive data collection, payer models and the impact of new regulations and innovative trial design on data collection and ongoing evidence provision.             Podcast Participants: Jim Clement – Partner & Board Member at Coeus Holdings                                        Donovan Quill – Executive Vice President at Terebellum

Click Therapeutics develops prescription software applications as medical devices that work independently or in conjunction with pharmacotherapies to treat disease. Click clinically validates these applications through rigorous randomized, controlled trials to demonstrate safety and efficacy. Guest: Shaheen Lakhan, MD, PhD Chief Medical Officer

Join us for a special guest interview this week with molecular plant scientist George Sellhorn, on a wide ranging interview around psilocybin and functional mushroom testing George Sellhorn Ph.D, is the founder, owner and Principal Scientist of Flourish Labs in Portland Oregon and earned his Ph.D. in Molecular Plant Sciences from Washington State University (2006) and his B.S. in Biology from Indiana University (1999). George has worked in both academia and the biotechnology industries from 2006-2021 working on projects such as HIV vaccine development, production, characterization and pre-clinical evaluation as well as bioconjugate-based therapeutics including pegylated interferon for multiple sclerosis, bifunctional antibodies and antibody drug conjugates for breast cancer and poly(carboxybetaine) L-asparaginase bioconjugates for acute lymphoblastic leukemia. George has 23 years of extensive experience with liquid chromatography using both High-Performance Liquid Chromatography (HPLC) and Fast protein liquid chromatography (FPLC) and these techniques are one of his primary expertise. Some of the leadership roles he has held in the laboratory include Senior Scientist, Laboratory Director and Principal Investigator. George has also worked in the medical and recreational Cannabis industries from 2009-2021 which included cultivation, processing and consulting in Washington, Oregon and Colorado. Flourish Labs, LLC was founded in August 2021 and opened its services to customers on January 1st , 2022. Link to George’s business here at Flourish Labs (OR): https://flourishlabsoregon.com/ Subscribe   Share Leave a comment Glossary of terms APE—Albino Penis Envy, considered one of the most potent strains of psilocybin cubensis in terms 4-ACO: Or O-acetylpsilocybin or 4-Aco-DMT: semi synthetic derivatives of psilocybin often used in pharmacologic studies BOL or 2-Br-LSD. Non hallucinogenic LSD derivative synthesized by Albert Hofman (who also synthesized LSD). CLIA and CAP: College of American pathologists and Clinical Laboratory Improvement Amendments—regulatory bodies for clinical laboratories. COA-certificate of analysis, offered by third party product testing labs. CRM: Certified Reference Materials (not Customer Relationship Management in this context) Entourage effect: hypothesis that compounds in cannabis other than CBD and THC act in synergy to exhibit pharmacologic effect (pretty good evidence to support this). GPCR: G protein coupled receptor: largest family of membrane proteins LOQ—Limit of quantification LOD—Level of detection. Level of detection is smallest concentration of a sample that can be consistently analyzed with 95% probability, LOQ is smallest concentration that can be measured with less than 10 to 20% variation. PSK (Krestin): Also known as Polysaccharide K, derived from Coriolus versicolor mushroom, widely used as folk remedy and adjuvant therapy for cancer treatment in some cultures. Terpenoids: Broad class of naturally occurring 5 Carbon molecules that show wide range of pharmacologic activities. 5-ME-O-DMT: Psychoactive drug derived from toad venom of glands of the Sonoran Desert toad (lots more to come on this).

Today's episode focuses on one pharmacists determination to push forward onto to phase II after not matching in phase I. Listen to hear her amazing story of resilience

Claudia Fox, MD, MPH, is a pediatrician and weight management specialist who specializes in pediatric preventive cardiology and family weight management. She sees patients at University of Minnesota Health Masonic Children's Hospital Pediatric Specialty Care Discovery Clinic, University of Minnesota Health Maple Grove Clinics and the Specialty Clinic for Children in Burnsville. Dr. Fox is also an associate professor as well as fellowship program director and faculty member in the Division of Pediatric Gastroenterology Hepatology and Nutrition in the Department of Pediatrics at the University of Minnesota Medical School. https://publications.aap.org/pediatrics/article/151/2/e2022060640/190443/Clinical-Practice-Guideline-for-the-Evaluation-and?autologincheck=redirected

In this episode of Q&A with FDA, we hear from Dr. Marta Sokolowska, Deputy Center Director for Substance Use and Behavioral Health in FDA’s Center for Drug Evaluation and Research, discuss the Agency’s vision as it relates to encouraging harm reduction, including expanding availability and access to lifesaving overdose reversal products. Dr. Sokolowska delves into the impacts of the recent approvals of nonprescription naloxone nasal spray as well as prescription nalmefene nasal spray, another medication for opioid overdose. 

Dr. Deborah Milito:  linkedin.com/in/deborah-milito-32a28156   Dr. Scott Stewart:  linkedin.com/in/scott-stewart-34973870   Dr. Tamara Ruggles:  linkedin.com/in/tamara-ruggles-491882251   CDC Core Elements of Antibiotic Stewardship for Nursing Homes:  https://www.cdc.gov/antibiotic-use/core-elements/nursing-homes.html   ASCP Antimicrobial Stewardship Toolkit:  https://www.med-pass.com/antimicrobial-stewardship-toolkit-for-long-term-care-with-usb-flash-drive.html     FDA Advisory Committee Calendar:  https://www.fda.gov/advisory-committees/advisory-committee-calendar       ACIP meeting information:  https://www.cdc.gov/vaccines/acip/meetings/index.html   Candida auris:  https://www.fda.gov/media/141083/download   Updated guidelines for Asymptomatic Bacteriuria:  https://www.idsociety.org/practice-guideline/asymptomatic-bacteriuria/   Clostridiodes difficile clinical practice guidelines:  https://www.idsociety.org/practice-guideline/clostridioides-difficile-2021-focused-update/   Community-Aquired Pneumonia guidelines:  https://www.atsjournals.org/doi/full/10.1164/rccm.201908-1581ST?role=tab       Please e-mail questions, comments, and funny pharmacy jokes to [email protected].  We would love to hear from you!

AJ Asgari, the CEO of Drugstore2Door, joined the Sports Pharmacy Podcast for a second round of discussion. We talked about their fitness journeys.  AJ shared his background, growing up in Oklahoma and initially planning to become a doctor before pivoting to pharmacy. He became an entrepreneur and currently owns nine pharmacies. AJ founded Drugstore2Door to address the challenges faced by independent pharmacies. The platform aims to digitize the entire pharmacy experience and provide a seamless online presence. They offer personalized website design, e-commerce capabilities, and services to help pharmacies generate additional revenue outside of PBMs. AJ emphasized the importance of customer feedback and continuous improvement in refining their product. Drugstore2Door's goal is to get as many independent pharmacies online as possible, allowing customers to access and pay for various pharmacy services. The platform covers prescription services, e-commerce, and other offerings, providing a turnkey solution for pharmacies. They are constantly developing new features and enhancements to make the integration seamless and user-friendly for pharmacies.

With more than 30 bills in progress this session at the federal level alone, PBM reform is barreling down the legislative tracks - but what's the best way to get legislation and enforcement across the finish line? Listen in as PUTT Executive Director, Monique Whitney, and Board Vice President, Lauren Young dive into the past, present, and (possible) future of PBM reform, who's getting it done, and why continuing to educate and follow through with legislation enforcement is such a critical component.

Bruce Kneeland attended the McKesson IdeaShare show and was able to interview several show attendees and learn from them some of what they saw, heard and learned at this show. Tips for making show attendance a success, examples of the benefits of networking and other ideas your peers will take home and implement are shared. If you did, or did not, attend this show you'll benefit from the comments on this podcast

A review of current literature around magic mushrooms for nicotine and alcohol dependency, end of life therapy, and more. Notes: Per Christopher Toney, a reminder that psilocybin dosing is based on dry weight of the whole mushrooms, for those curious about how dosing is calculated. How well does this approximate actual psilocybin content? This will be a good future topic for discussion. References: Link to FDA’s Considerations for Clinical Investigations of Psychedelic Drugs (Accessed 11 July 2023): https://www.fda.gov/regulatory-information/search-fda-guidance-documents/psychedelic-drugs-considerations-clinical-investigations.   Bogenschutz MP, et al. Percentage of heavy drinking days following psilocybin assisted psychotherapy vs placebo in the treatment of patients with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2022; 79(10): 953-962 https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2795625 Carhart-Harris R, et al. Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine. 2021: 384: 1402-1411. https://www.nejm.org/doi/full/10.1056/nejmoa2032994 Ebbesen-Jensen M, et al. Psilocybin assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomized, double blinded, placebo controlled 12 week clinical trial (the QUANTUM trip trial). BMJ Open. 2022; 12(10). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577917/ Ercolano, A. (2023) Johns Hopkins Center for psychedelic and Consciousness Research, Johns Hopkins Medicine. Available at: https://www.hopkinsmedicine.org/psychiatry/research/psychedelics-research.html Fauber J and Fiore K. Slippery slope: Fen-Phen users recall a “miracle” turned nightmare. Milwaukee Journal Sentinel/Med Page Today. 19 April 2015. https://www.medpagetoday.com/special-reports/slipperyslope/51044 Goodwin GM, et al. Single dose psilocybin for treatment for a treatment resistant episode of major depression. New England Journal of Medicine. 2022; 387(18). https://www.nejm.org/doi/pdf/10.1056/NEJMoa2206443?articleTools=true Griffiths RR, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double blind trial. Journal of Psychopharmacology. 2016; 30(2): 1181-1197 Grob CS, et al. Pilot study of psilocybin for anxiety in patients with advanced stage cancer. JAMA Psychiatry. 2011; 68(1): 71-78. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/210962 Kenney A. What to know about Colorado’s psychedelic law. Colorado Public Radio. 21 June 2023. https://www.cpr.org/2023/06/21/colorado-psychedelic-law-for-psilocybin-mushrooms/ Rosenbaum D, et al. Psychedelics for existential distress in palliative and cancer care. Current Oncology. 2019; 26(4): 225-226. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726261/ Ross S, et al. Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life threatening cancer. ACS Pharmacology and Translational Science. 2021; 4(2): 553-562. https://pubmed.ncbi.nlm.nih.gov/33860185/ Rotz VR, et al. Single dose psilocybin assisted therapy in major depressive disorder: a placebo controlled, randomized double blind trial. The Lancet. 2023;56: 101809. https://www.thelancet.com/action/showPdf?pii=S2589-5370%2822%2900538-7   To read about “Mad Honey” that we referenced towards the end of the podcast: see here: https://bigthink.com/health/mad-honey/#:~:text=But%20what%20really%20distinguishes%20mad,%2C%20in%20rare%20cases%2C%20death.

Hello everyone! I don’t know about you but this last week has been feeling a bit heavy for me. However, this episode is just the thing for you if you’re feeling the same weight, because I’m interviewing Alex Barker of The Happy PharmD.  Alex’s mission is to transform the profession so every pharmacist can unlock their career’s potential. He strives for pharmacists to love pharmacy again. Alex Barker is the CEO and Founder of The Happy Pharm D, a nationwide coaching firm guiding pharmacists to inspiring careers and more fulfilling lives. Alex is an accomplished public speaker, a published author and teacher. Since 2017, his coaching program and career development seminars have guided over 2,000 pharmacists into new jobs and roles they love.  His book “Indispensable: A prescription for a fulfilling pharmacy career,” has motivated countless pharmacists to love pharmacy again. Alex is a husband and the proud father of two daughters. He loves drinking coffee and eating good guacamole (though not at the same time). When he isn’t working, which happens occasionally, he plays Nintendo, Dungeon & Dragons, and reads comics. This episode is very near and dear to my heart because Alex’s blog has put me on the scene of pharmacy experts in the natural and holistic space, and I’m forever grateful. I can’t wait to share this next episode with you so here it is!  Check out The Happy PharmD at: Website: Thehappypharmd.com LinkedIn: The Happy PharmD Instagram: @thehappypharmd Facebook: @The Happy PharmD

What’s Your Mission? What’s Your Purpose? On 'This Week in Pharmacy" Jennifer Bourgeois, Pharm.D is on the pods. She's a pharmacist, a mother, and an amazing Provider in McKinney, Texas. Dr. Bourgeois serves as a SingleCare spokesperson after being named Best Pharmacist in 2021. Next, catching up on biosimilars with Stephen Pagnotta, Executive Director and Biosimilar Commercial Lead at Boehringer Ingelheim.  A biosimilar is a biological medicine highly similar to another already approved biological medicine (the 'reference medicine'). Biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. We're talking about Cyltezo!